News & Markets | Nirvana Systems Inc.- Part 8

Category Archives for "News & Markets"

UCASU: Navigating for the new normal

By Beth Senko, CFA OTC:UCASU READ THE FULL UCASU RESEARCH REPORT The pandemic continues to throw uncertainty into the economy and markets, making it difficult, if not impossible, for many to look past 2020, or even next week. Recent studies suggest that in the past three months, between six and eight million Americans have fallen into poverty, creating additional concerns for landlords and other small businesses.

Continue reading

BCLI: Phase 3 ALS Data Due Soon…

By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Topline Data from Phase 3 ALS Trial Before End of November 2020 BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) is currently conducting a Phase 3 clinical trial of NurOwn® in patients with amyotrophic lateral sclerosis (ALS) (NCT03280056). A total of 200 patients were randomized 1:1 to receive NurOwn® or placebo in the randomized, double blind, placebo controlled, multi-dose trial. Cells were extracted once from each patient prior to treatment, with all administrations of NurOwn® derived from the same extraction of cells due to a cryopreservation process the company developed for long-term storage of mesenchymal stem cells (MSC).

Continue reading
1 6 7 8
>